Gut microbiota mediates semaglutide attenuation of diabetes-associated cognitive decline

Diabetes-associated cognitive decline (DACD), characterized by cognitive impairment, is a serious complication of diabetes mellitus (DM). Research has shown that semaglutide, a novel glucagon-like peptide-1 receptor agonist, has neurotrophic and neuroprotective properties. However, a comprehensive u...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Liqin Qi, Huimin Kang, Feihui Zeng, Menglan Zhan, Cuihua Huang, Qintao Huang, Lijing Lin, Guanlian He, Xiaoying Liu, Xiaohong Liu, Libin Liu
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2025-09-01
Cyfres:	Neurotherapeutics
Pynciau:	Semaglutide Cognitive impairment Gut microbiota Neuroactive ligand-receptor interactions Metabolome
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S1878747925000935
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!